China’s plans to import Indian drugs fail to enthuse Indian pharma firms


China’s much-publicised announcement to slash tariffs on 28 medicines, including cancer drugs from India, has failed to create any buzz among the Indian pharmaceutical firms in Beijing as exports to China are possible only after lengthy field trials and approvals, which could take years.
Read more at Hindustan Times.

Translate »